# Treatment of Patients With Anxiety Disorder (0777-022)

> **NCT00539578** · PHASE2 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 270 (actual)

## Conditions studied

- Generalized Anxiety Disorder

## Interventions

- **DRUG:** MK0777
- **DRUG:** Comparator: placebo (unspecified)

## Key facts

- **NCT ID:** NCT00539578
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** 2003-02
- **Final completion:** 2003-02
- **Target enrollment:** 270 (ACTUAL)
- **Last updated:** 2015-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00539578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00539578, "Treatment of Patients With Anxiety Disorder (0777-022)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00539578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*